Literature DB >> 4281483

Drug treatment of diseases characterized by abnormal movements.

C D Marsden.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4281483      PMCID： PMC1645440     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  18 in total

1.  The effect of tetrabenazine in some hyperkinetic syndromes.

Authors:  H Pakkenberg
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

2.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

3.  Similarities between neurologic effects of L-dopa and of apomorphine.

Authors:  G C Cotzias; P S Papavasiliou; C Fehling; B Kaufman; I Mena
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

4.  Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol.

Authors:  P H Connell; J A Corbett; D J Horne; A M Mathews
Journal:  Br J Psychiatry       Date:  1967-04       Impact factor: 9.319

5.  Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa.

Authors:  R E Barrett; M D Yahr; R C Duvoisin
Journal:  Neurology       Date:  1970-11       Impact factor: 9.910

6.  Modification of sympathetic function. Pharmacological depletion of catecholamine stores.

Authors:  A Carlsson
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Peripheral beta-adrenergic receptors concerned with tremor.

Authors:  C D Marsden; T H Foley; D A Owen; R G McAllister
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

8.  Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine.

Authors:  H Nybäck; G Sedvall; I J Kopin
Journal:  Life Sci       Date:  1967-11-01       Impact factor: 5.037

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Effect of tetrabenazine on extrapyramidal movement disorders.

Authors:  M A Dalby
Journal:  Br Med J       Date:  1969-05-17
View more
  7 in total

Review 1.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 2.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

Review 3.  Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.

Authors:  Arun Kumar Verma; Eshan Khan; Sonali R Bhagwat; Amit Kumar
Journal:  Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.590

4.  Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Authors:  M Bartels; E Zeller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 5.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

Review 6.  How Many Dystonias? Clinical Evidence.

Authors:  Alberto Albanese
Journal:  Front Neurol       Date:  2017-02-03       Impact factor: 4.003

7.  Tourette syndrome research highlights from 2017.

Authors:  Andreas Hartmann; Yulia Worbe; Kevin J Black
Journal:  F1000Res       Date:  2018-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.